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This special edition of the Biomedical Journal puts the innate immune system into the
limelight. We learn about the universal mechanisms underlying the immediate defense
against influenza viruses mounted by innate immunity but also its detrimental secondary
effects and how differential host genetics influence the network. Moreover, this issue
addresses how oral hygiene is a concern for the entire organism, that younger age goes
well with neoadjuvant chemotherapy for breast cancer and zinc with feeling less dis-
tressed by tinnitus caused by noise-induced hearing loss, and that IL-1Ra holds very
promising potential to prevent intestinal ischemia reperfusion injury. Finally, we discover
which type of post optimally protects devitalized teeth from breaking and how difficult it is
to accurately diagnose the macrofollicular variant of papillary thyroid carcinoma.Spotlight on reviews
Evergreen influenza e tackling an old enemy with fresh
munitions
Time goes by, but influenza remains. One century after the
ravages of the worst influenza pandemic ever, the 1918
Spanish Flu, and despite major progress in research and
vaccination strategies, influenza persists in being one of the
most common viral infections worldwide [1,2]. Moreover,
globalization, climate change, the boom of human mobility
plus the massive intensification of livestock farming have
fanned the embers of pandemic threats over the last decade..
g Gung University.
ublishing services by Else
s/by-nc-nd/4.0/).Continuously changing versions of the influenza A virus (IAV)
have bestowed on us the H5N1 “bird flu” and the H1N1 “swine
flu” pandemics in 2006 and 2009 respectively, as well as the
threats by H7N9 in 2013 [3]. On the other hand, the revolution
of molecular biology and genetics from the second half of the
20th century on has unveiled bit by bit the sheer complexity of
the cellular and molecular mechanisms behind the host
pathogen encounter, shaped by the everlasting arms race of
co-evolution. This novel understanding of the intricatemenage
a trois of microbes and both the innate and the adaptive im-
mune system has certainly provided us with a new angle of
attack against influenza [4]. However, the fragile balance be-
tween efficient pathogen elimination and collateral damage tovier B.V. This is an open access article under the CC BY-NC-ND
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 1e42the host has made it extremely difficult to fine-tune the sys-
tem [5].
The innate immune system in times of influenza - friend and foe
In our first Special Edition review, Carmelo Biondo et al. pay
tribute to the complex role performed by the innate immune
system upon influenza infection [6]. Until adaptive immunity
becomes operational following invasion by the pathogen, it
takes aminimumof five days, duringwhich the innate system
has to battle and maintain the invader on its own. Unfortu-
nately, it also tends to go too far, leading to excessive systemic
inflammation and life-threatening tissue injury [7].
At the cellular level, the authors describe how these de-
fenses are strategically stationed at the organism level, from
alveolar macrophages patrolling the boundary to the outside
world to dendritic cells presenting viral antigens to naı¨ve
lymphocytes. As for the molecular realm, recognition and
defense modules are present in all cellular compartments.
Biondo et al. walk us in great detail through the sector of Toll-
like receptors (TLRs), the interferon system, the plethora of
pro-inflammatory cytokines and the inflammasome, always
making sure to outline both the protective and potentially
detrimental effects of each module [Fig. 1]. In addition, they
highlight the crucial role that countless mouse models have
played in deciphering the exact role of individual components
of the innate immune system, but also their pitfalls. For
example, most standard inbred mouse strains lack a func-
tional MX1 and/or MX2 protein and are thus per se more sus-
ceptible to influenza.Fig. 1 Example of signal transduction cascades triggered by influe
ssRNA elements and RIG-1 viral RNA, and trigger the NF-kB interfe
See main article for details.Given the complicated dual role in protection and danger of
the majority of the innate immune system, the authors sug-
gest focusing rather on the dampening of downstream effec-
tors, like neutrophil extracellular traps (NETs), production of
reactive oxygen species (ROS) or IL-17 secretion.
Nonetheless, after this detailed portrait of the universal
interface between innate immunity and influenza infection,
DanielleWellington et al. question this very universality in our
second review by addressing how differences in host genetics
condition the severity of influenza infection [8]. Despite the era
of -omics and thepopularity of genomewide association studies
(GWAS) for a multitude of features and diseases [9], the matter
remains complex because of the strong interdependence with
other genetic or environmental factors, lack of clinical samples
and the share of viral strain variance [8]. Regardless, a certain
number of genetic variations and their links with influenza
susceptibility are known todate, all of them fromthe front lines
of host defenses against viral invasion, such as single nucleo-
tide polymorphisms (SNPs) in TLR or antimicrobial genes.
The authors though draw our attention to a more myste-
rious member of the host pathogen interplay, the interferon
induced trans-membrane protein 3 (IFITM3). Mainly induced
by interferons of types I and II, IFITM3 inhibits the propagation
of many enveloped RNA viruses by preventing the release of
viral particles from endosomal compartments, although the
mechanistic details are still unclear [10,11].
Intriguingly, IFITM3 presents two SNPs, both associated
with an increased severity of influenza infection, but one
present mainly in European and the other in Asiannza virus infection. TLR3/7 recognize 50 tri-phosphorylated
ron pathways. Figure kindly provided by Wellington et al. [8].
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 1e4 3populations. The first one, rs34481144, is localized in the gene
promoter and seems to prompt epigenetic repression of the
entire genomic region by CTCF recruitment, thus lowering
IFITM3 expression [12]. SNP rs12252 in turn is to date themost
prevalent genetic association with severe influenza infection,
yet the underlying mechanisms are unknown so far [13,14].
The authors stress the value that a better understanding of
IFITM3 function and tissue-specific expression holds for tun-
ing it eventually to dampen influenza infection severity.Also in this issue
Reviews
Tooth brushing benefits the entire organism
The oral cavity is home to 500e700 bacterial taxa that
compose the oral microbiome, normally living in a mutually
beneficial coexistence with the human body [15]. The taking
over by pathogenic species leads to gum inflammation known
as periodontitis.
Bui et al. focus on an accumulating body of evidence how
periodontal pathogens could potentially extend their damage
to distant organs and cause systemic disease, either by bac-
terial dissemination, release of endotoxins and metabolic
byproducts into the bloodstream or as a consequence of in-
flammatory mediators [16]. They present multiple examples
strongly suggesting an interrelationship between periodonti-
tis and many diseases including cardiovascular disease, res-
piratory tract infections, oral and colorectal cancer, diabetes
mellitus, Alzheimer's disease and adverse pregnancy out-
comes, prompting them to stress the potential of the oral
cavity both as a diagnostic tool and target for therapeutic
intervention for non-oral systemic diseases.
Original articles
IL-1Ra protects against intestinal ischemia reperfusion injury
Ischemia reperfusion (I/R) injury refers to severe tissue damage
caused by secondary inflammation and oxidative stress once
the blood supply has been restored. The small intestine is the
most sensitive organ to I/R injury, with high fatality rates due to
the spread of inflammation to multiple distant organs [22]. The
naturally occurring interleukin-1 receptor antagonist (IL-1Ra)
has already attracted quite some interest as for its potential
ability to counteract IL-1 in inflammation and autoimmune
diseases [23,24]. Here, Jin et al. explore its effect on intestinal I/R
injury in a rat model [25]. They demonstrate that IL-1Ra
administration substantially reduces tissue damage,
apoptosis, inflammation and oxidative stress. Besides the ex-
pected inhibition of IL-1 targets, the authors provide evidence
for an activation of the Nrf2/HO-1 pathway by IL-1Ra as a mo-
lecular mechanism underlying the dampening of reactive oxy-
gen species. The results could indicate a novel, promising
therapeutic application of IL-1Ra in intestinal I/R injury patients.
Zinc supplementation improves the perception of disease
severity in patients with noise-induced hearing loss
High zinc concentrations in the cochlea, ensuring the activity
of the superoxide dismutase SOD1, protect the sensitive haircells from damage by reactive oxygen species [20]. Tinnitus is
one of the most frequent hearing disturbances and due to the
spontaneous depolarization of auditory fibers, creating noise
without any acoustic stimulus, but its pathophysiology is still
unclear. Several studies have observed hypo-zincemia in
tinnitus patients and some an improvement of the condition
after zinc supplementation, while others report no effect.
These discrepancies might be linked to the heterogeneity of
tinnitus patients. Therefore, Yeh et al. investigate here the
effectiveness of zinc supplementation in a subgroup of noise-
induced hearing loss patients suffering additionally from
tinnitus [21]. They conclude that although there were no im-
provements in objective hearing parameters, 85% of patients
showed amelioration in a subjective evaluation of life quality
restriction due to the tinnitus.
Optimization of post systems for tooth restoration after root
canal treatment
Root canal treatment consists in the removal of the nerve of
the tooth, which often entails a substantial structure loss that
renders the tooth highly weakened. Functional restoration
usually requires a post to support a core by increasing the
surface between tooth and reconstruction. The rigidity and
stiffness of the post material influences its resistance to the
permanent mechanical stresses exerted on teeth. €Oztu¨rk et al.
undertake a comparison of the fracture resistance and mode
of extracted and endodontically treated thin-walled teeth
restored with different post systems by subjecting them to
increasing mechanical constraints [26]. The authors find that
the cast post displays the highest and the I-TFC post the
lowest fracture resistance, while a glass-fiber post and an I-
TFC post allow for tooth repair following fracture.
The challenging diagnosis of macrofollicular variant of papillary
thyroid carcinoma
The macrofollicular variant of papillary thyroid cancer
(MFVPTC) is a rare subtype of the follicular variant of papillary
thyroid carcinoma (FVPTC) [27]. Although the clinical course
tends to be indolent, delayed recurrence and extensive lymph,
bone or lung metastases can occur in some cases, stressing
the importance of correct diagnosis. Even so, the latter is
complicated by the similarities with benign lesions [28]. In
order to refine diagnostic reference points, Ng et al. retro-
spectively skimmed the thyroid cancer database for specific
MFVPTC features [29]. According to their study, generic diag-
nosis tools such as ultrasonography (US) and fine needle
aspiration cytology (FNAC) are suboptimal for MFVPTC
recognition because the consensus malignant US features are
not always present in these tumors and the nuclear features
too subtle to be observed by FNAC. Given that the 100% sur-
vival rate after MFVPTC surgery, an improved diagnosis seems
advisable.
Younger age correlates with better outcomes after neoadjuvant
chemotherapy in locally advanced breast cancer
Neoadjuvant chemotherapy (NAC) is routinely used in order to
reduce the tumor size prior to surgery of advanced breast
cancer [17]. The absence of residual invasive tumor in the
tissue sample removed during surgery is termed pathological
complete response (pCR) and has been shown to predict
b i om e d i c a l j o u r n a l 4 2 ( 2 0 1 9 ) 1e44favorable long-term outcomes. Various parameters have been
correlated with higher pCR rates. Yet, the influence of age on
either pCR or locoregional recurrence (LRR) after NAChave not
been extensively assessed, although one study finds that
younger age is a predictor for LRR after breast-conserving
surgery (BCS) but not mastectomy [18]. Here, Chou et al.
investigate the connection between patient age and either
pCR or LRR after NAC. In contrast to the previous study, the
authors find that younger age is an independent factor to
predict both pCR and LRR-free survival [19].Conflicts of interest
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